Cargando…
Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma
Liposarcoma is one of the most common subtypes of soft-tissue sarcoma and consists of three main subtypes, of which well-differentiated liposarcoma and dedifferentiated liposarcoma account for 40–45%. The current mainstay of systemic treatment for patients with metastatic or unresectable disease rem...
Autores principales: | McGovern, Yevette, Zhou, Charlie D., Jones, Robin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715199/ https://www.ncbi.nlm.nih.gov/pubmed/29250486 http://dx.doi.org/10.3389/fonc.2017.00292 |
Ejemplares similares
-
Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations
por: Codenotti, Silvia, et al.
Publicado: (2019) -
Case report: Paratesticular dedifferentiated liposarcoma with poor prognosis
por: Suto, Hirotaka, et al.
Publicado: (2022) -
Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in Liposarcoma
por: Tseng, William W., et al.
Publicado: (2016) -
Dedifferentiated liposarcoma of the left kidney: A rare case report
por: Li, Chiao-Ching, et al.
Publicado: (2018)